Emergency contraception using progestin drugs in domestic cats


Keywords: cats, contraception, progestin, non-surgical methods.

Abstract

Today, in conditions of strict quarantine, when it is not always possible to carry out surgery in cats, some methods of emergency drug contraception can be used. Over the years, many contraceptive medications have been developed for companion animals, but many secondary adverse effects have limited their use. However, in all species, the secondary adverse effects of progesterone-type drugs limit their use and vary depending on when treatment is given in relationship to the stage of the estrous cycle. An ideal non-surgical sterilant would be safe, effective, permanent, administered as a single injection and capable of being manufactured inexpensively. Contraceptives are used for cats, as a method of renewable fertility over time for breeding animals, as a method of suppressing sexual function for animals at risk for surgery, and to prevent over populations in stray cats. The use of non-surgical, safe and effective methods of suppression of sexual function in cats eliminates traumatization, anesthesia and complicated postoperative period in animals, which in some cases are impossible in the state of health, etc. The most common and affordable method of medical contraception is progestins, such as megestrol acetate, medroxyprogesterone acetate, proligestone (used orally or as a depot injection). These drugs are effective in inhibiting sexual function. Contraceptives for felids are available as implants, depot injections, and pills or liquid for oral administration, powder for mixing with food, or as vaccines. Regimens may differ according to the timing of first treatment, whether coinciding with the active reproductive period, preceding this period, or during anestrus. Ideally, the treatment regimen is initiated during anestrus to minimize the dose needed for reproductive suppression and to avert exposure to endogenous steroids that can cause lesions in reproductive organs.

References

Burke, T. J. (1982). Pharmacologic control of estrus in the bitch and queen. Vet Clin North Am Small Anim Pract., 12(1), 79–84. doi: 10.1016/s0195-5616(82)50007-1.

Cathey, M., & Memon, M. A., (2010). Nonsurgical methods of contraception in dogs and cats: Where are we now? Vet. Med., 105, 12–17. https://www.dvm360.com/view/nonsurgical-methods-contraception-dogs-and-cats-where-are-we-now.

Chatdarong, K., Rungsipipat, A., Axnér, E., & Linde Forsberg, C. (2005). Hysterographic appearance and uterine histology at dif-ferent stages of the reproductive cycle and alter progestagen treatment in the domestic cat. Theriogenology, 64(1), 12–29. doi: 10.1016/j.theriogenology.2004.10.018.

Conneely, M. O., Mulac-Jericevic, B., & Lydon, P. J. (2003). Pro-gesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids, 68(10-13), 771–778. doi: 10.1016/S0039-128X(03)00126-0.

Evans, J. M., & Sutton, J. D. (1989). The use of hormones, espe-cially gestagens, to control oestrus in bitches. J. Reprod. Fertil. Supp., 39, 163–173. http://agris.fao.org/agris-search/ search.do?recordID=GB9013627.

Fagerstone, K. A., Miller, L. A., Killian, G., & Yoder, C. A. (2010). Review of issues concerning the use of reproductive inhibitors, with particular emphasis on resolving human wildlife conflicts in North America. Integrative Zoology, 5(1), 15–30. doi: 10.1111/j.1749-4877.2010.00185.x.

Hafez, E. S. E., Jainudeen, M. R., & Rosnina, Y. (2000). Hor-mones, growth factors, and reproduction. In: Hafez ESE, Hafez B, editors. Reproduction in farm animals. Philadelphia, PA: Lippincott Williams and Wilkins, 33–54. doi: 10.1002/9781119265306.ch3.

Jurka, P., & Max, A., (2009). Treatment of fibroadenomatosis in 14 cats with aglepristone. Vet. Rec., 165(22), 657–660. doi: 10.1136/vr.165.22.657.

Keskin, A., Yilmazbas, G., Yilmaz, R., Ozyigit, M. O., & Gumen, A. (2009). Pathological abnormalities after long-term administra-tion of medroxyprogesterone acetate in a queen. J. Feline Med. Surg., 11(6), 518–521. doi: 10.1016/j.jfms.2008.10.006.

Kim, K. S., & Kim, O. (2005). Cystic endometrial hyperplasia and endometritis in a dog following prolonged treatment of medrox-yprogesterone acetate. J. Vet. Sci., 6, 81–82.

Kutzler, M., & Wood, A. (2006). Non-surgical methods of contra-ception and sterilization. Theriogenology, 66(3), 514–525. doi: 10.1016/j.theriogenology.2006.04.014.

Loretti, A. P., IIha, M. R. S., Ordás, J., & Martín de las Mulas, J. (2005). Clinical, pathological and immunohistochemical study of feline mammary fibroepithelial hyperplasia following a single in-jection of depot medroxyprogesterone acetate. J Feline Med Surg, 7, 43–52. doi: 10.1016/j.jfms.2004.05.002.

Max, A., & Jurka, P. (2006). Skutki uboczne stosowania gestagenów u psów i kotów [Adverse effects after administra-tion of gestagens in dogs and cats]. Med. Weter., 62, 508–511 (in Polish).

Munson, L. (2006). Contraception in felids. Theriogenology, 66(1), 126–134. doi: 10.1016/j.theriogenology.2006.03.016.

Oen, E. O. (1977). The oral administration of megestrol acetate to postpone oestrus in cats. Nord Vet Med, 29(6), 287–291. https://europepmc.org/article/med/896408.

Plumb, D. C. (2002). Veterinary Drug Handbook, 4th ed., Ames: Iowa State Press. https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC372247.

Romagnoli, S., & Concannon, P. W. (2003). Clinical use of proges-tins in bitches and queens: a review. In: Concannon PW, Eng-land G, Verstegen J, Linde-Forsberg C, eds. Recent advance in small animal reproduction. Ithaca NY.

Reichler, I. M. (2009). Gonadectomy in cats and dogs: a review of risk and benefits. Reprod Dom Anim, 44(2), 29–35. doi: 10.1111/j.1439-0531.2009.01437.x.

Romagnoli, S. (2015). Progestins to control feline reproduction: Historical abuse of high doses and potentially safe use of low doses. J Feline Med Surg., 17(9), 743–752. doi: 10.1177/1098612X15594987.

Romatowski, J. (1989). Use of megestrol acetate in cats. J Am Vet Med Assoc., 194, 700–702.

Struthers, R. S. (2012). Gonadotrophinreleasing hormone targeting for gonadotroph ablation: an approach to non-surgical steriliza-tion. Repro Domest Anim, 47(4), 233–238. doi: 10.1111/j.1439-0531.2012.02081.x.

Vasetska, A., & Mass, A. (2018). Method of medical contraception of female cats. Patent № 122925. Ukraine. published 25.01.2018, Bull. № 2 (in Ukrainian).

Vasetska, A., & Stefanyk, V. (2018). Method of comlex medica-mental contraception in females of domestic animals. Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences, 20(83), 352–356. doi: 10.15421/nvlvet8370.

Wildt, D. E., Brown, J. L., Swanson, W. F., Knobil, E., & Neill, J. D. (1998). Encyclopedia of reproduction. Reproduction in felids. New York, NY: Academic Press, 497–510.
Published
2020-05-17
How to Cite
Vasetska, A. (2020). Emergency contraception using progestin drugs in domestic cats. Ukrainian Journal of Veterinary and Agricultural Sciences, 3(2), 3-6. https://doi.org/https://doi.org/10.32718/ujvas3-2.01